Brief: Monopar Therapeutics Announces Promising Pre-clinical Data For Its MNPR-101 Radiopharma Program Targeting Advanced Cancers
22/02/2024 14:28
Feb 22 (Reuters) - Monopar Therapeutics Inc MNPR.O :
* MONOPAR THERAPEUTICS INC - ANNOUNCES PROMISING PRECLINICAL
DATA
FOR ITS MNPR-101 RADIOPHARMA PROGRAM TARGETING ADVANCED CANCERS
Source text for Eikon: ID:n0001437749-24-005127
Further company coverage: MNPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla